How Does PET-CT Imaging Support Personalized Cancer Care?

Not all patients have the same experiences with cancer. The location, stage, growth pattern, and response to treatment may vary even for two people with the same type of cancer. That is why, for cancers, which can be a variety of different types, doctors can look at detailed information about a patient's cancer and decide on the best course of action.

An important aspect of this is PET-CT imaging, as a Positron Emission Tomography (PET) scan reveals the parts of the body where the metabolic rate is higher, and a Computed Tomography (CT) scan along with a PET scan gives both functional and anatomical data. This helps doctors determine the location of the cancer, the activity or vigor of the cancer, if the cancer has spread, and how well it is responding to therapy. Most advanced services of nuclear medicine and diagnostic imaging are provided at Molecular Diagnosticsand Therapy, in order to provide an integrated evaluation of the cancer with state-of-the-art PET-CT scanning services.

What Is PET-CT Imaging?

PET is a type of measurement known as “Positron Emission Tomography”. It is a type of nuclear medicine imaging that reveals increased activity in the body with the administration of a small quantity of radioactive tracer.

Fluorodeoxyglucose, or FDG, is one of the most commonly used tracers in cancer imaging. Glucose uptake is increased in cancer compared to some normal tissues in many cancers. PET is often used in conjunction with CT, as a PET demonstrates metabolic or biological activity, and CT demonstrates the size, shape, and position of tissues.

What Is an Oncology PET-CT Scan?

An oncology PET-CT scan is a scan specifically used to evaluate cancer. It is used to help the doctor assess the extent of the primary tumor, nearby lymph nodes, and whether they have spread to other parts of the body.

This information is helpful in various phases of treatment for cancer. In some instances, a PET-CT is ordered before treatment, during treatment, or after treatment, depending on the type and stage of cancer. This scan cannot replace a biopsy or another test, but offers valuable information in addition to a biopsy.

PET-CT Scan for Cancer Staging

The process of finding the stage of cancer is one of the important steps in planning treatment. Staging provides doctors with clues about the extent to which the disease has spread. A PET/CT scan might help localize areas of heightened metabolism that might be cancer. The CT part helps doctors with the anatomical information that gives them more information on where these areas are. Accurate staging can assist doctors in determining whether surgery, radiation therapy, chemotherapy, immunotherapy, targeted treatment, or a combination of the above might be appropriate.

Finding Cancer That Has Spread

In some cases, cancer may spread from the place it began to the lymph nodes or to other parts of the body. The spreading of disease from one place to another is called metastasis. In some cases, doctors might use PET-CT to detect places in the body with abnormal activity, depending on the cancer and tracer used. Having a list of potential spread sites alters treatment plans and may avoid unnecessary procedures if a different treatment plan is more appropriate.

However, elevated activity of a tracer does not necessarily mean cancer. Elevated activity is also found in infection, inflammation, and some normal tissues. Thus, PET interpretations should always be done by trained experts, in conjunction with other clinical data.

Helping Doctors Choose the Right Treatment

Personalized cancer care involves choosing treatment based on the particular nature of the cancer. Using PET imaging to depict the location and intensity of cancer could help with this. For instance, if PET-CT can be used to identify areas of disease, a treatment approach might be developed that treats the entire body and not just one tumor.

In some cases, imaging might also be useful to determine that the disease is localized, in which a more precise treatment protocol might be appropriate. Treatment is determined by various factors such as biopsy results, type of cancer, stage of cancer, molecular characteristics, general health, and prior treatments.

Monitoring Response to Treatment

Monitoring response to cancer therapy is another important application of PET imaging. Even if cancer activity has reduced, the tumor may not show a size reduction immediately after treatment. Structural imaging alone, however, may not necessarily give all the answers.

An FDG PET-CT scan is able to detect changes in the metabolic rate. If uptake is reduced, this may indicate that the cancer is less active and may not need to be regarded as a cause for concern; if uptake is still present or has increased, then this may mean that the cancer is still active and further investigation is needed. Comparing scans at relevant time periods to see how the treatment is working.

Detecting Recurrence

Doctors might want to keep an eye out for signs of cancer after treatment to see if it's come back. PET-CT is useful to detect suspicious areas if cancer recurrence is suspected, depending on the type of cancer and the overall clinical situation. It can offer a source of functional information which can supplement CT, MRI, blood tests and physical examination and subsequent investigations.

Why Is FDG PET-CT Commonly Used?

FDG is a substance that is similar to glucose and can help make areas of the body with higher glucose activity stand out. FDG can be used to measure the uptake of glucose in many types of cancer, which also exhibit increased glucose use.

But not all cancers act the same. Other specialised tracers are more appropriate for some cancer types, and some tumors may have low uptake of FDG. According to the forecast of the disease, the image-producing method and tracer are chosen for the clinical needs.

PET Imaging and Personalized Cancer Care

To deliver personalized cancer care, it must be based on the right information at the right time in the right person's session. PET imaging can differentiate its role in knowing the activity and location of disease. Data from a PET-CT scan help inform the decision on diagnosis, staging, choice of treatment, treatment management, or the evaluation of suspected recurrence.

Remember that the CT and PET combination is part of a comprehensive cancer check. Imaging results are taken together with the medical history, physical examination, symptoms, and pathology, along with other tests that the doctor may have ordered.

Is PET-CT Safe?

PET- CT has a small amount of radioactive tracer. Amount based upon the examination and patient needs. The tracer passes out of the body over time normally. The CT exam exposure is from X-rays; therefore, when the expected medical benefit is more than the possible risk, the test is indicated.

Pregnant women or those breastfeeding should inform their health care team. They also need to adhere to instructions for preparation, which are presented before the scan, especially when using FDG with respect to diet and blood sugar.

PET-CT at Molecular Diagnostics and Therapy

Molecular Diagnostics and Therapy offers state-of-the-art PET-CT services to aid in the thorough evaluation of cancer. Advanced imaging technologies can assist your health care professional in determining the extent of cancer and monitoring the response to treatment, as well as for follow-up when appropriate. The images are used to help diagnose the problem in conjunction with the patient's medical history and other tests.

Conclusion

PET imaging is one of the key elements of today's personalized cancer care. A PET-CT scan of the body is performed to help find out whether the disease is active and, if so, what the location of it is, all of which can be useful when the type of cancer is being staged, when a person is planning treatment, if someone's disease is responding to their treatment, or if they have suspected recurrent cancer.

It's often used to look for places that are more active in using glucose, particularly in many cancers, and is known as an FDG PET-CT scan. In some cases, however, PET-CT is not an alternative for an individual patient or for all cancers, and the scan is determined by a person's illness.

Molecular Diagnostics and Therapy provides cancer imaging that is accurate and complete, thanks to diagnostic technology and modern nuclear medicine services, helping doctors to make well-informed decisions as patients move through their treatment journey.